Wednesday, June 10, 2026
🇺🇸 FDA

pharma · Breast Cancer · Prostate Cancer · UTHR

United Therapeutics Europe

United Therapeutics Europe Ltd

United Therapeutics Europe clinical programs — 184 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Website Investor relations
1000 Spring Street, Silver Spring, Maryland 20910, US HQ
1996 Founded
1,443 Employees
Public company Type
UTHR · NYSE Ticker
Company details
Status
Public
HQ
1000 Spring Street, Silver Spring, Maryland 20910, US
Founded
1996
Employees
1,443
Programs
1032
Drugs
612
Patents
3720
Official website ↗ All projects Drug pipeline Patents News & analysis

Recent coverage

View all news & analysis →
Intelligence · Clinical Programs

United Therapeutics Europe projects

184 ClinicalTrials.gov programs sponsored by United Therapeutics Europe.

United Therapeutics Europe has 184 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

All phases Phase III Phase II Phase I NDA / BLA filed Approved programs

184 programs

Clinical programs

Page 2 of 4

  1. Dendritic Cell Vaccine

    United Therapeutics Europe Ltd

    Leptomeningeal Disease

    phase 1 mab active

    1 trial

  2. Dinutuximab

    United Therapeutics Europe Ltd

    Neuroblastoma

    phase 1 small molecule active

    2 trials

  3. Docetaxel

    United Therapeutics Europe Ltd

    Prostate Cancer

    phase 1 small molecule completed

    1 trial

  4. Doxorubicin

    United Therapeutics Europe Ltd

    Pancreatic Ductal Adenocarcinoma

    phase 1 small molecule terminated

    1 trial

  5. EVOLVE104

    United Therapeutics Europe Ltd

    Bladder Cancer

    phase 1 small molecule active

    1 trial

  6. Ebola Vaccine - low dose

    United Therapeutics Europe Ltd

    Ebola Virus Disease

    phase 1 mab completed

    1 trial

  7. Emtricitabine

    United Therapeutics Europe Ltd

    HIV

    phase 1 small molecule completed

    1 trial

  8. Encapsulated Calcium

    United Therapeutics Europe Ltd

    Pregnancy

    phase 1 other completed

    1 trial

  9. Endo Tool

    United Therapeutics Europe Ltd

    Burns

    phase 1 other completed

    1 trial

  10. Etanercept

    United Therapeutics Europe Ltd

    Gulf War Illness

    phase 1 small molecule active

    1 trial

  11. External non-invasive stimulation

    United Therapeutics Europe Ltd

    TBI (Traumatic Brain Injury)

    phase 1 other active

    1 trial

  12. FGI-101-1A6

    United Therapeutics Europe Ltd

    Influenza

    phase 1 small molecule active

    1 trial

  13. FMP012 with AS01B adjuvant system

    United Therapeutics Europe Ltd

    Malaria

    phase 1 mab completed

    1 trial

  14. FMP1/AS02A

    United Therapeutics Europe Ltd

    Malaria

    phase 1 mab completed

    1 trial

  15. Gallium-68 citrate

    United Therapeutics Europe Ltd

    Prostatic Neoplasms

    phase 1 small molecule completed

    1 trial

  16. Glucagon

    United Therapeutics Europe Ltd

    Type 1 Diabetes Mellitus With Hypoglycemia

    phase 1 small molecule completed

    1 trial

  17. Glucose

    United Therapeutics Europe Ltd

    Diabetes Mellitus

    phase 1 other completed

    1 trial

  18. Glyburide

    United Therapeutics Europe Ltd

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  19. Granulocyte Colony-Stimulating Factor

    United Therapeutics Europe Ltd

    Biliary Atresia

    phase 1 small molecule completed

    1 trial

  20. Group 1: 10 ug FMP012 with 2 ug GLA-SE

    United Therapeutics Europe Ltd

    Malaria

    phase 1 mab completed

    1 trial

  21. Group A Deactivated TENS with beeping sound (15-second interval)

    United Therapeutics Europe Ltd

    Healthy

    phase 1 other completed

    1 trial

  22. Guadecitabine

    United Therapeutics Europe Ltd

    Non Small Cell Lung Cancer

    phase 1 small molecule active

    1 trial

  23. Human interferon alfa 1b inhalation solution

    United Therapeutics Europe Ltd

    Healthy Participants

    phase 1 small molecule completed

    1 trial

  24. Hyperpolarized xenon

    United Therapeutics Europe Ltd

    Lung Disease

    phase 1 small molecule completed

    1 trial

  25. IMM-BCP-01

    United Therapeutics Europe Ltd

    SARS-CoV2 Infection

    phase 1 small molecule terminated

    1 trial

  26. ITX 5061

    United Therapeutics Europe Ltd

    Hepatitis C

    phase 1 small molecule completed

    1 trial

  27. Ibuprofen

    United Therapeutics Europe Ltd

    Tonsillectomy With or Without Adenoidectomy

    phase 1 small molecule terminated

    1 trial

  28. Ibuprofen 800 mg

    United Therapeutics Europe Ltd

    Bone Resorption

    phase 1 small molecule completed

    1 trial

  29. Image Guided Dynamic Dosimetry

    United Therapeutics Europe Ltd

    Locally Confined Adenocarcinoma of the Prostate

    phase 1 other completed

    1 trial

  30. Imatimib Mesylate

    United Therapeutics Europe Ltd

    Lymphangioleiomyomatosis (LAM)

    phase 1 small molecule active

    1 trial

  31. Influenza A/California/04/09

    United Therapeutics Europe Ltd

    Influenza A

    phase 1 mab active

    1 trial

  32. Influenza A/Texas/71/2017 (H3N2)

    United Therapeutics Europe Ltd

    Influenza Viral Infections

    phase 1 mab completed

    1 trial

  33. Intravenous Artesunate

    United Therapeutics Europe Ltd

    Solid Tumors

    phase 1 small molecule completed

    1 trial

  34. Itraconazole

    United Therapeutics Europe Ltd

    Non-small Cell Lung Cancer

    phase 1 small molecule completed

    1 trial

  35. KRAS Vaccine with Poly-ICLC adjuvant

    United Therapeutics Europe Ltd

    Colorectal Cancer

    phase 1 small molecule active

    1 trial

  36. Ketamine

    United Therapeutics Europe Ltd

    Acute Depression

    phase 1 small molecule terminated

    1 trial

  37. Ketorolac

    United Therapeutics Europe Ltd

    Pain, Post-operative

    phase 1 small molecule completed

    1 trial

  38. LS11

    United Therapeutics Europe Ltd

    Neurofibroma

    phase 1 small molecule terminated

    1 trial

  39. Leukocyte Interleukin, Injection 200IU

    United Therapeutics Europe Ltd

    Condyloma

    phase 1 small molecule terminated

    1 trial

  40. Liposomal bupivacaine

    United Therapeutics Europe Ltd

    Pain, Postoperative

    phase 1 small molecule completed

    1 trial

  41. Losartan potassium

    United Therapeutics Europe Ltd

    Emotional Processing

    phase 1 small molecule active

    1 trial

  42. Losartan potassium 50mg

    United Therapeutics Europe Ltd

    Social Cognition

    phase 1 small molecule active

    1 trial

  43. Losartan potassium 50mg

    United Therapeutics Europe Ltd

    Emotional Processing

    phase 1 small molecule active

    1 trial

  44. Lumason Contrast-Enhanced Ultrasound

    United Therapeutics Europe Ltd

    Kidney Transplantation

    phase 1 small molecule terminated

    1 trial

  45. Lumason® contrast agent

    United Therapeutics Europe Ltd

    Mitochondrial Myopathies

    phase 1 small molecule active

    1 trial

  46. MGD020

    United Therapeutics Europe Ltd

    HIV (Human Immunodeficiency Virus)

    phase 1 small molecule active

    1 trial

  47. Magellan®

    United Therapeutics Europe Ltd

    Acute Burns

    phase 1 other active

    1 trial

  48. Mammaglobin-A DNA Vaccine

    United Therapeutics Europe Ltd

    Breast Cancer

    phase 1 mab active

    1 trial

Frequently asked questions

How many clinical projects does United Therapeutics Europe have?

184 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.